Semaglutide

Semaglutide is a GLP-1 receptor agonist peptide used in the management of type 2 diabetes and chronic weight management. It works by mimicking the natural GLP-1 hormone, which helps regulate blood sugar levels, slow gastric emptying, and reduce appetite, leading to improved glycemic control and weight reduction.

In clinical use and research, semaglutide is studied for its effects on metabolic health, including insulin secretion, satiety signaling, and long-term weight loss outcomes. It is commonly administered as a once-weekly injection or in oral form, depending on the formulation.

Because of its strong effects on appetite and glucose regulation, semaglutide is widely researched in obesity and metabolic disorder treatment programs, often showing significant improvements in body weight, blood sugar control, and cardiovascular risk markers.